Halozyme

HYLENEX

Manufacturer:

Halozyme

Hylenex HCPCS:

J3473

HCPCS Code Descriptor:

Injection, hyaluronidase, recombinant, 1 usp unit

Category:

J Code

Hylenex NDCs:

18657-0117-04

Primary Type:

Unclassified

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Injection

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

18657-0117-04

About Hylenex:

HYLENEX is an Unclassified drug manufactured by Halozyme and administered via the Injection route of administration. The J Code: J3473 is aligned to the drug HYLENEX.

ACCESS PRICING AND MORE BY REGISTERING

J3473 Added Date:

January 1, 2007

J3473 Effective Date:

January 1, 2007

J3473 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Hylenex billing and coding information.
Our team did not identify a source for Hylenex patient assistance information. Please reach out to our team if you feel that this is a mistake.
HYLENEX prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for HYLENEX. Please check back in a few weeks.